Abstract PS5-12-29: Fertility Outcomes In Young Breast Cancer Patients And Their Prognosis And Offspring Health

Abstract Background: Most young breast cancer patients (≤40 years old) are in the golden period of fertility, but chemotherapy is prone to premature ovarian failure, and radiotherapy and long-term endocrine therapy further compress the fertility window. In addition, in response to the current controversy over fertility behavior on patient prognosis and the research gap in the long-term health of offspring with anti-tumor therapy, we designed this retrospective cohort study to clarify the fertility status of young breast cancer patients, verify the independent impact of fertility behavior on the prognosis of patients with different molecular types, and evaluate the association between treatment regimens and offspring health. Methods: This was a multicenter retrospective study on fertility outcomes and their prognosis and offspring health in young breast cancer patients. Based on the breast cancer database, we registered the baseline data of young breast cancer patients (≤40 years old), including age at initial diagnosis, molecular typing, tumor stage, treatment plan, fertility protection measures, etc., and followed up by telephone/email and other means to collect their fertility status, recurrence and offspring growth and development data. The primary endpoints were the disease-free survival (DFS), overall survival (OS) after childbirth and childrens’ growth and development. The secondary endpoints were the patient's fertility live birth rate, pregnancy outcomes and complications, use of fertility preservation techniques, breastfeeding status, etc. We used the Kaplan-Meier method to draw the survival curve of the patients after childbirth, and analyzed the growth trajectory of the offspring born after diagnosis by the Lambda-Mu-Sigma method, and plotted the growth and development curve. We used Log-rank to test the significance of differences in pregnancy rates between variables. We used Univariate Cox regression analysis to screen factors related to prognosis, and then used multivariate Cox regression analysis to adjust for potential confounding factors to clarify independent prognostic indicators of disease. Finally, descriptive analyses were performed for other secondary outcomes. Citation Format: A. Yuan, Z. Hu, C. Zheng, Z. Zheng, W. Liang, Y. Yuan, W. Wang, C. Zhang, Y. Pan, Y. Zhang. Fertility Outcomes In Young Breast Cancer Patients And Their Prognosis And Offspring Health [abstract]. In: Proceedings of the San Antonio Breast Cancer Symposium 2025; 2025 Dec 9-12; San Antonio, TX. Philadelphia (PA): AACR; Clin Cancer Res 2026;32(4 Suppl):Abstract nr PS5-12-29.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2026-02-17
DOI
https://doi.org/10.1158/1557-3265.sabcs25-ps5-12-29
Primary Topic
Reproductive Biology and Fertility
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract PS5-12-29: Fertility Outcomes In Young Breast Cancer Patients And Their Prognosis And Offspring Health

Weizhen Liang, Zhe Hu, Yin Pan, Changjun Zheng et al.
Clinical Cancer Research
Reproductive Biology and Fertility
article

Abstract PS5-12-29: Fertility Outcomes In Young Breast Cancer Patients And Their Prognosis And Offspring Health

Weizhen Liang, Zhe Hu, Yin Pan, Changjun Zheng, Z. Zheng, Y. Yuan, Y. Zhang, C. Zhang, A. Yuan, W. Wang
article en

Abstract

Abstract Background: Most young breast cancer patients (≤40 years old) are in the golden period of fertility, but chemotherapy is prone to premature ovarian failure, and radiotherapy and long-term endocrine therapy further compress the fertility window. In addition, in response to the current controversy over fertility behavior on patient prognosis and the research gap in the long-term health of offspring with anti-tumor therapy, we designed this retrospective cohort study to clarify the fertility status of young breast cancer patients, verify the independent impact of fertility behavior on the prognosis of patients with different molecular types, and evaluate the association between treatment regimens and offspring health. Methods: This was a multicenter retrospective study on fertility outcomes and their prognosis and offspring health in young breast cancer patients. Based on the breast cancer database, we registered the baseline data of young breast cancer patients (≤40 years old), including age at initial diagnosis, molecular typing, tumor stage, treatment plan, fertility protection measures, etc., and followed up by telephone/email and other means to collect their fertility status, recurrence and offspring growth and development data. The primary endpoints were the disease-free survival (DFS), overall survival (OS) after childbirth and childrens’ growth and development. The secondary endpoints were the patient's fertility live birth rate, pregnancy outcomes and complications, use of fertility preservation techniques, breastfeeding status, etc. We used the Kaplan-Meier method to draw the survival curve of the patients after childbirth, and analyzed the growth trajectory of the offspring born after diagnosis by the Lambda-Mu-Sigma method, and plotted the growth and development curve. We used Log-rank to test the significance of differences in pregnancy rates between variables. We used Univariate Cox regression analysis to screen factors related to prognosis, and then used multivariate Cox regression analysis to adjust for potential confounding factors to clarify independent prognostic indicators of disease. Finally, descriptive analyses were performed for other secondary outcomes. Citation Format: A. Yuan, Z. Hu, C. Zheng, Z. Zheng, W. Liang, Y. Yuan, W. Wang, C. Zhang, Y. Pan, Y. Zhang. Fertility Outcomes In Young Breast Cancer Patients And Their Prognosis And Offspring Health [abstract]. In: Proceedings of the San Antonio Breast Cancer Symposium 2025; 2025 Dec 9-12; San Antonio, TX. Philadelphia (PA): AACR; Clin Cancer Res 2026;32(4 Suppl):Abstract nr PS5-12-29.

Clinical Cancer ResearchVol. 32(4_Supplement)
Taizhou Central Hospital (CN), Taizhou University (CN)
Good health and well-being
Openalex Percentile: Top 55%
Reproductive Biology and Fertility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.